Christopher Kirk
Founder at KEZAR LIFE SCIENCES, INC.
Net worth: 340 765 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Graham Cooper | M | 54 | 7 years | |
| Michael Kauffman | M | 60 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 10 years |
| John Fowler | M | 52 | 9 years | |
| Franklin Berger | M | 74 | 8 years | |
| Marc Belsky | M | 68 | 6 years | |
| Micki Klearman | M | 69 | 3 years | |
| Courtney Wallace | F | 40 | 3 years | |
| Elizabeth Garner | M | 56 | 5 years | |
| Laurie B. Lippin | M | - |
University of California, Davis
| 34 years |
| Gary D. Hammer | M | - |
University of Michigan
| 25 years |
| Thomas N. Gladwin | M | 74 |
University of Michigan
| 26 years |
| Pattie Chiang | F | - | - | |
| Zung To | M | - | - | |
| Mark Christopher Schiller | M | - | 5 years | |
| Allen S. Lichter | M | 77 |
University of Michigan
| 26 years |
| Gitanjali Jain | F | - | 3 years | |
| Michelle Greenman | F | - | - | |
| Jinhai Wang | M | - | - | |
| Andrea Fan | M | - | 9 years | |
| Li Long | M | - | - | |
| Nick Mordwinkin | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| N. Coles | M | 63 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 years |
| Stein John | M | - |
University of Michigan
| 12 years |
| David J. Scott | M | 71 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| Jean-Pierre Sommadossi | M | 68 | 7 years | |
| Brian Scott Stutland | M | 49 |
University of Michigan
| 6 years |
| Michael Wolfe | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Adam Lipman | M | - |
University of California, Davis
| 14 years |
| Keenan Kwok | M | - |
University of Michigan
| 5 years |
| Walter Joseph Liu | M | 45 |
University of Michigan
| 5 years |
| Jason Robert Dinges | M | 48 | 3 years | |
| Chi Ho Wong | M | 45 |
University of Michigan
| 5 years |
| Zoltan Gombosi | M | - |
University of Michigan
| 6 years |
| Simeon Denchev Djankov | M | 54 |
University of Michigan
| - |
| Jason Park | M | 47 |
University of Michigan
| 5 years |
| Tonya Bakritzes | F | - |
University of Michigan
| 5 years |
| Sriram Ryali | M | 43 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 4 years |
| Richard Anthony Consul | M | - |
University of Michigan
| 11 years |
| Robert G. Wilson | M | - |
University of Michigan
| 2 years |
| Vassiliki Economides | F | 44 | - | |
| Li Wang | M | 55 |
University of California, Davis
| 7 years |
| Mark A. Borsos | M | - |
University of Michigan
| 7 years |
| Farrokh Ayazi | M | - |
University of Michigan
| 4 years |
| Marc L. Walinsky | M | - |
University of Michigan
| 5 years |
| Ben Lewis | M | 43 |
University of Michigan
| 7 years |
| Kaspar von Braun | M | 53 |
University of Michigan
| 5 years |
| Daniel Beltzman | M | 49 |
University of Michigan
| 5 years |
| Jonathan McQueen | M | 55 |
University of California, Davis
| 5 years |
| Steven Scott Rodriguez | M | - |
University of Michigan
| 5 years |
| Maicie Jones | F | - |
University of Michigan
| 12 years |
| Mike Flanagan | M | - |
University of Michigan
| 10 years |
| Vicky Vergilius Gunawan | M | 41 |
University of Michigan
| 6 years |
| Pablo Cagnoni | M | 60 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Eric Norman Pryor | M | 58 |
University of California, Davis
| 6 years |
| Helen Torley | M | 61 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Gil Omenn | M | 83 |
University of Michigan
| - |
| Antonio J. Grillo-López | M | 84 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 11 years |
| Paul Goddard | M | 74 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 16 years |
| Wendell Wierenga | M | 76 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 17 years |
| Magnus Åke Lundberg | M | 68 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 13 years |
| William Ringo | M | 78 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Thomas Wiggans | M | 72 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 8 years |
| Bihua Chen | F | 55 | - | |
| Thomas Leon Szymoniak | M | - |
University of California, Davis
| 7 years |
| Mike K. Jung | M | 54 |
University of Michigan
| 3 years |
| Brian Stephen Matuszak | M | - |
University of Michigan
| 6 years |
| Adil Haque | M | - |
University of Michigan
| 4 years |
| Bruce Cameron Greig | M | - |
University of Michigan
| 9 years |
| Jason B. Koenig | M | - |
University of Michigan
| 7 years |
| Dave Repp | M | - |
University of Michigan
| - |
| James Bunn | M | 51 |
University of Michigan
| 4 years |
| Adam P. Wise | M | - |
University of Michigan
| 5 years |
| Annie Maxwell | F | - |
University of Michigan
| 5 years |
| Jay F. Whitacre | M | - |
University of Michigan
| 3 years |
| Elizabeth Maclin | F | - |
University of Michigan
| 2 years |
| Erik Perkins | M | - |
University of Michigan
| 5 years |
| Michael O'Reilly | M | 70 |
University of Michigan
| 12 years |
| John M. Long | M | - |
University of Michigan
| 4 years |
| Robert Kasdin | M | 66 |
University of Michigan
| 5 years |
| Marcelo Adrian Desio | M | - |
University of Michigan
| 2 years |
| Rebecca L. Javid | F | - |
University of Michigan
| 4 years |
| Evan R. Gallinson | M | - |
University of Michigan
| 4 years |
| Michael K. Coddington | M | - |
University of Michigan
| 3 years |
| Brett Feldman | M | - |
University of Michigan
| 4 years |
| Andrew C. P. Chang | M | - |
University of Michigan
| 4 years |
| Wayee Chu | F | - |
University of Michigan
| 4 years |
| Kristy Corcoran | F | - |
University of Michigan
| 4 years |
| Jeffrey Gordon | M | - |
University of Michigan
| 4 years |
| Shelly Hundiwal | F | - |
University of Michigan
| 4 years |
| Kelvin Pan | M | 44 |
University of Michigan
| 4 years |
| James E. Elworth | M | - |
University of Michigan
| 4 years |
| Wes Cornwell | M | - |
University of Michigan
| 4 years |
| Christopher A. Vittoz | M | - |
University of Michigan
| 4 years |
| Ken Herbert | M | - |
University of Michigan
| 2 years |
| Brian Mulloy | M | - |
University of Michigan
| 4 years |
| Egan Park | M | - |
University of Michigan
| 4 years |
| Drusilla Scott | M | 70 |
University of Michigan
| 6 years |
| Damon McLaughlin | M | - |
University of Michigan
| 4 years |
| Adam Daniel Silver | M | - |
University of Michigan
| 4 years |
| Kirkland B. Vashaw | M | - |
University of Michigan
| 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christopher Kirk
- Personal Network
